Syed Ali Adnans Post *Breaking News* The US Food and Drug Administration (FDA) has approved Tirzepatide for chronic weight management in adults with obesity (body mass index of 30 kilograms per square meter (kg/ m2) or greater) or overweight (body mass index of 27 kg/m2 or greater) with at least one weight-related condition (such as high blood pressure, type 2 diabetes or high cholesterol) for use, in addition to a reduced calorie diet and increased physical activity
Its value lies not just in what it does, but in how it can be applied : Muscle Growth: By activating IGF-1 receptors, it drives muscle cell proliferation and enhanced glucose uptake, fueling lean tissue development
I can confidently get my patients to their weight loss goals on semaglutide or tirzepatide, used at the lowest effective dose with proper functional medicine support
The timeline varies based on dose, body chemistry, and individual metabolism, but clinical data shows most people experience appetite suppression within the first week and measurable weight loss by week three to four of consistent use
A standard powder capsule has very different bioavailability than a liposomal liquid
